MedPath

Post-traumatic Arthritis Associated With Joint Injury

Completed
Conditions
Arthritis
Interventions
Procedure: Tissue sample collection at the time of surgery
Registration Number
NCT01792791
Lead Sponsor
Duke University
Brief Summary

Arthritis is the nation's most common cause of disability. An estimated 50 million U.S. adults (about 1 in 5) report doctor-diagnosed arthritis. Twenty three million U.S. adults of working age (18-64 years) have arthritis; and in this age group arthritis-attributable work limitations affect about 1 in 3 people. An estimated 12% of all patients seeking intervention for symptomatic arthritis have an etiology of previous trauma to the involved joint.

The purpose of this study is to examine these inflammatory compounds in the joint fluid (synovial fluid), the joint lining (synovium), and in blood among subjects with isolated intra-articular fractures.

The hypothesis is that early levels of intra-articular inflammation and markers of joint tissue degeneration following articular fracture in the human knee are predictive of the development of PTA (Post Traumatic Arthritis). Early levels of intra-articular inflammation and markers of joint tissue degeneration identified from human knee joints following articular injury are predictive of the development of PTA in the mouse knee.

Samples of blood, urine and synovial fluid will be taken at the spanning frame surgery and only synovial fluid at the ORIF (Open Reduction Internal Fixation)surgery. Two MRIs (Magnetic Resonance Imaging) will be part of this study at 4 weeks and 18 months.Participants will complete a set of questionnaires(KOOS: Knee Injury and Osteoarthritis Outcome Score) at 4 weeks and 18 months.

Detailed Description

40 patients with a closed unilateral articular fracture of the knee requiring operative treatment will be enrolled over an 18 month period. Tissue samples including synovial fluid from the injured and contralateral knee, serum and urine will be collected pre-operatively at the time of framing and ORIF. If patients only need to have one surgery (ORIF) sample will be collected only once. MRI imaging of the injured knee will be obtained after fixation at between week 6 and 8 and at 18 months. Tissue samples will be analyzed for established biomarkers of joint inflammation and degradation. Patients will be followed for 18 months to assess for signs of post-traumatic arthritis. Imaging with plain film and MRI will occur at 18 months. MRI imaging analysis of cartilage thickness and composition changes will be assessed in the injured knees. Assessment of articular cartilage and joint space narrowing and KOOS will be correlated to biomarkers that may be indicative and predictive of joint degeneration and the development of PTA.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Subjects will be adult patients (over 18 years old)
  • Patients must present with a unilateral closed intra-articular fracture of the knee.
Read More
Exclusion Criteria
  • Pre-existing arthritis in the injured or contra-lateral knee,
  • Previous total knee replacement
  • Active joint infection
  • Pathologic fracture
  • Active inflammatory arthritis
  • Open fracture of the involved knee
  • Contra-lateral knee injury
  • HIV infection (if previously known)
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Single ArmTissue sample collection at the time of surgery-
Primary Outcome Measures
NameTimeMethod
Markers of joint tissue degeneration following articular fracture18 months after Injury

Tissue samples will be collected at the time of surgery and they will be taken to Duke Basic Science lab where they will be analyzed.

Secondary Outcome Measures
NameTimeMethod
KOOS questionnaireParticipants will complete this questionnaire at the 18 month follow up

Participants will be scheduled for an MRI 18 months after surgery and a questionnaire will be completed at that time.

Trial Locations

Locations (1)

Duke University Medical Center

🇺🇸

Durham, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath